These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 25688915)

  • 61. F2 locus equations: phonetic descriptors of coarticulation in 17- to 22-month-old children.
    Gibson T; Ohde RN
    J Speech Lang Hear Res; 2007 Feb; 50(1):97-108. PubMed ID: 17344551
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vowel Formants in Normal and Loud Speech.
    Koenig LL; Fuchs S
    J Speech Lang Hear Res; 2019 May; 62(5):1278-1295. PubMed ID: 31084509
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease.
    Dumer AI; Oster H; McCabe D; Rabin LA; Spielman JL; Ramig LO; Borod JC
    J Int Neuropsychol Soc; 2014 Mar; 20(3):302-12. PubMed ID: 24524211
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vowel space characteristics and vowel identification accuracy.
    Neel AT
    J Speech Lang Hear Res; 2008 Jun; 51(3):574-85. PubMed ID: 18506036
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effectiveness of Lee Silverman Voice Treatment (LSVT) on hypernasality in non-progressive dysarthria: the need for further research.
    Wenke RJ; Theodoros D; Cornwell P
    Int J Lang Commun Disord; 2010; 45(1):31-46. PubMed ID: 19565392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Parkinson's disease and the effect of lexical factors on vowel articulation.
    Watson PJ; Munson B
    J Acoust Soc Am; 2008 Nov; 124(5):EL291-5. PubMed ID: 19045680
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clear Speech Variants: An Acoustic Study in Parkinson's Disease.
    Lam J; Tjaden K
    J Speech Lang Hear Res; 2016 Aug; 59(4):631-46. PubMed ID: 27355431
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acoustic differences between content and function words in amyotrophic lateral sclerosis.
    Turner GS; Tjaden K
    J Speech Lang Hear Res; 2000 Jun; 43(3):769-81. PubMed ID: 10877444
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The progress in the rehabilitation of dysarthria in Parkinson disease using LSVT (Lee Silverman Voice Treatment)].
    Kamińska I; Zebryk-Stopa A; Pruszewicz A; Dziubalska-Kołaczyk K; Połczyńska-Fiszer M; Pietrala D; Przedpelska-Ober E
    Otolaryngol Pol; 2007; 61(5):713-8. PubMed ID: 18552005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vocalic transitions as markers of speech acoustic changes with STN-DBS in Parkinson's Disease.
    Martel-Sauvageau V; Tjaden K
    J Commun Disord; 2017 Nov; 70():1-11. PubMed ID: 29032347
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Feasibility of group voice therapy for individuals with Parkinson's disease.
    Searl J; Wilson K; Haring K; Dietsch A; Lyons K; Pahwa R
    J Commun Disord; 2011; 44(6):719-32. PubMed ID: 21889774
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characteristics of the lax vowel space in dysarthria.
    Tjaden K; Rivera D; Wilding G; Turner GS
    J Speech Lang Hear Res; 2005 Jun; 48(3):554-66. PubMed ID: 16197272
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Invariants, specifiers, cues: an investigation of locus equations as information for place of articulation.
    Fowler CA
    Percept Psychophys; 1994 Jun; 55(6):597-610. PubMed ID: 8058448
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Respiratory Responses to Two Voice Interventions for Parkinson's Disease.
    Richardson K; Huber JE; Kiefer B; Kane C; Snyder S
    J Speech Lang Hear Res; 2022 Oct; 65(10):3730-3748. PubMed ID: 36167066
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Cross-Language Study of Acoustic Predictors of Speech Intelligibility in Individuals With Parkinson's Disease.
    Kim Y; Choi Y
    J Speech Lang Hear Res; 2017 Sep; 60(9):2506-2518. PubMed ID: 28821018
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tongue- and Jaw-Specific Articulatory Underpinnings of Reduced and Enhanced Acoustic Vowel Contrast in Talkers With Parkinson's Disease.
    Mefferd AS; Dietrich MS
    J Speech Lang Hear Res; 2019 Jul; 62(7):2118-2132. PubMed ID: 31306611
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The influence of speaking rate on vowel space and speech intelligibility for individuals with amyotrophic lateral sclerosis.
    Turner GS; Tjaden K; Weismer G
    J Speech Hear Res; 1995 Oct; 38(5):1001-13. PubMed ID: 8558870
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of contrast in limiting vowel-to-vowel coarticulation in different languages.
    Manuel SY
    J Acoust Soc Am; 1990 Sep; 88(3):1286-98. PubMed ID: 2229663
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The relationship between perception and acoustics for a high-low vowel contrast produced by speakers with dysarthria.
    Bunton K; Weismer G
    J Speech Lang Hear Res; 2001 Dec; 44(6):1215-28. PubMed ID: 11776360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.